Belgium· BE-AMP-SAM468480-00
Lynparza 50 mg
A olaparib product containing olaparib, registered in Belgium by AstraZeneca. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Olaparib is registered in 2 of 19 countries.
Countries holding a registration under ATC L01XX46 (olaparib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 1 of them publish a price we can compare per daily dose
Olaparib · ATC L01XX46
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Olaparib
- Manufacturer
- AstraZeneca
- Country
- Belgium (BE)
- ATC code
- L01XX46
- ATC class
- Olaparib
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7714165
- be_apb3203197
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
507 interactions on record for olaparib.
Graded by severity as the source publishes them — 104 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olaparib · interactions on record
507 records
- 104 severe
- 400 moderate
- 3 minor
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- DronedaroneC01BD07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olaparib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLYNPARZA 50 MG CAPSULAS DURASAstrazeneca Ab
- United KingdomLynparza 50mg capsulesAstraZeneca UK Ltd
- SwedenLynparza 50 mg Kapsel, hårdAstraZeneca AB
- SwitzerlandLynparza 100 mg, FilmtablettenAstraZeneca AG
- CzechiaLYNPARZAAstraZeneca AB, Södertälje
- FinlandLynparzaAstraZeneca AB
- United StatesLynparzaAstraZeneca Pharmaceuticals LP
- CanadaLYNPARZAASTRAZENECA CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lynparza
- Liechtenstein · Lynparza
- Norway · Lynparza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/73fd34e6-467d-4b52-8aab-6a4c95949eae GET /v1/drugs/73fd34e6-467d-4b52-8aab-6a4c95949eae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Lynparza 50 mg",
"name_fr": "Lynparza 50 mg",
"name_nl": "Lynparza 50 mg",
"amp_code": "SAM468480-00",
"strengths": [
"50.0000",
"50.0000"
],
"pack_count": 1,
"substances": [
"Olaparib",
"Potassium Acetate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Olaparib",
"authorisation_numbers": [
"EU/1/14/959/001"
]
}See everything about olaparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.